Jacques Philippe Caen

Jacques Philippe Caen's AcademicInfluence.com Rankings

Philosophy

#4543

World Rank

#7104

Historical Rank

Logic

#1971

World Rank

#2857

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jacques Philippe Caen's Degrees

Doctorate Medicine Université Paris Cité

Why Is Jacques Philippe Caen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jacques Philippe Caen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Glanzmann's thrombasthenia: the spectrum of clinical disease. (1990) (738)
An Abnormal Platelet Glycoprotein Pattern in Three Cases of Glanzmann's Thrombasthenia (1974) (446)
Specific roles for platelet surface glycoproteins in platelet function (1975) (393)
Induction of acetylcholinesterase expression during apoptosis in various cell types (2002) (300)
Congenital bleeding disorders with long bleeding time and normal platelet count: I. Glanzmann's thrombasthenia (report of fifteen patients) (1966) (295)
Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. (1992) (225)
Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. (1993) (217)
Binding and endocytosis of heparin by human endothelial cells in culture. (1985) (216)
Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. (1981) (207)
Analogy between fibrinogen and casein (1986) (181)
Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. (1990) (175)
Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. (1976) (173)
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. (1998) (173)
Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. (1986) (172)
Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome. (1980) (168)
Monoclonal Antibody to Human Platelet Glycoprotein I I. IMMUNOLOGICAL STUDIES (1981) (167)
Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. (1993) (166)
Monoclonal Antibody to Human Platelet Glycoprotein I II. EFFECTS ON HUMAN PLATELET FUNCTION (1981) (140)
Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function. (1981) (140)
Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment. (2002) (135)
Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis. (1989) (135)
Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. (1981) (134)
Determination of platelet antigens and glycoproteins in the human fetus. (1986) (134)
Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. (1981) (133)
Transfusion Studies in von Willebrand's Disease: Effect on Bleeding Time and Factor VIII (1963) (127)
Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. (1999) (121)
Relationship between Fibrinogen Binding and the Platelet Glycoprotein Deficiencies in Glanzmann's Thrombasthenia Type I and Type II (1981) (113)
Endothelial binding sites for heparin. Specificity and role in heparin neutralization. (1986) (113)
Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface. (1987) (107)
Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. (1997) (98)
Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation. (1991) (94)
A Randomized Double-Blind Study Between a Low Molecular Weight Heparin Kabi 2165 and Standard Heparin in the Prevention of Deep Vein Thrombosis in General Surgery (1988) (92)
Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand's disease (report of thirty-seven patients). (1968) (90)
New functions for platelets and their pathological implications. (1985) (89)
Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His. (1987) (87)
Heparin degradation in the endothelial cells. (1987) (87)
Association between coagulation factors VII and X with triglyceride rich lipoproteins. (1988) (86)
Further studies of the human platelet receptor for quinine- and quinine-dependent antibodies. (1981) (86)
Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots. (1996) (85)
Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3',4'-bisphosphate. (1991) (82)
Coagulation Factor VII and Plasma Triglycerides (1989) (79)
Dysfibrinogenemia (Fibrinogen Dusard) Associated with Impaired Fibrin-Enhanced Plasminogen Activation (1984) (78)
SURVIVAL OF RADIOCHROMIUM-LABELED PLATELETS IN THROMBOCYTOPENIAS. (1963) (78)
Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed-immunoelectrophoresis. (1981) (77)
Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. (1987) (77)
Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome (1982) (76)
Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser. (1988) (76)
Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines. (1999) (75)
A new type of congenital dysfibrinogenaemia with defective fibrin lysis—Dusard syndrome: possible relation to thrombosis (1983) (74)
Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes. (1990) (74)
5 Glanzmann's thrombasthenia (1989) (72)
Thromboxane Synthesis and the Platelet Release Reaction in Bernard‐Soulier Syndrome, Thrombasthenia Glanzmann and Hermansky‐Pudlak Syndrome (1977) (71)
The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets. (1979) (71)
Evidence that abnormal platelet functions in human Chédiak-Higashi syndrome are the result of a lack of dense bodies. (1983) (70)
Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents (1999) (68)
Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease. (1976) (68)
Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation. (1988) (66)
New approach to determination of specific functions of platelet membrane sites (1976) (64)
Acquired von Willebrand's syndrome and thrombopathy in a patient with chronic lymphocytic leukaemia. (2009) (63)
Ultrastructural demonstration of CD36 in the alpha-granule membrane of human platelets and megakaryocytes. (1993) (63)
Hageman factor, platelets and polyphosphates: early history and recent connection (2010) (62)
Regulation of calcium accumulation and efflux from platelet vesicles. Possible role for cyclic-AMP-dependent phosphorylation and calmodulin. (1983) (62)
Bleeding in renal failure: a possible cause. (1976) (62)
Availability of Platelet Factor 3 and Activation of Factor XII in Thrombasthenia (1965) (62)
Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from kappa-casein on platelet function. (1986) (61)
Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura (1990) (61)
Prostaglandins: specific inhibition of platelet adhesion to collagen and relationship with cAMP level. (1982) (60)
Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium. (1983) (60)
KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction. (1990) (60)
Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes (1990) (59)
Aggregation, adhesion, and viscous metamorphosis of platelets in congenital fibrinogen deficiencies. (1966) (58)
Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy (1975) (57)
Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree. (1991) (57)
A molecular defect in thrombasthenic platelets. (1975) (57)
Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome. (1982) (56)
Expression of von Willebrand factor in porcine vessels: Heterogeneity at the level of von Willebrand factor mRNA (1989) (56)
Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture. (1984) (55)
Interaction of blood platelets with a microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor. (1983) (55)
Detection of abnormal platelet functions with an in vitro model of primary haemostasis. (1985) (53)
Tenth Annual Meeting of the European Association for the Study of Diabetes (1974) (53)
Increased adhesion to fibronectin and Mo-1 expression by diabetic monocytes. (1987) (53)
Comparative Arterial Antithrombotic Activity of Clopidogrel and Acetyl Salicylic Acid in the Pig (1992) (53)
Platelet prothrombin converting activity in hereditary disorders of platelet function (1986) (53)
Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation. (2001) (53)
Negative Regulation of Mitogen-activated Protein Kinase Activation by Integrin αIIbβ3 in Platelets* (1997) (52)
Inheritance of the human platelet alloantigen, PlA1, in type I Glanzmann's thrombasthenia. (1981) (51)
Selective binding of heparins to human endothelial cells. Implications for pharmacokinetics. (1987) (51)
Fibrin polymerization is crucial for thrombin generation in platelet‐rich plasma in a VWF–GPIb‐dependent process, defective in Bernard–Soulier syndrome (2004) (50)
Biologically active peptides of casein and lactotransferrin implicated in platelet function (1989) (49)
New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor β1 (1992) (49)
Interaction between platelets and von Willebrand factor provides a new scheme for primary haemostasis. (1973) (48)
Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium. (1986) (47)
Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function (1978) (47)
Molecular defect in platelets from patients with bernard-soulier syndrome. (1977) (47)
Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators (1996) (46)
Thrombocytopenic c-mpl(-/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response. (2001) (45)
Studies on a new variant of the Hermansky‐Pudlak syndrome: Qualitative, ultrastructural, and functional abnormalities of the platelet‐dense bodies associated with a phospholipase a defect (1978) (45)
Relationship Between Mepacrine-Labelled Dense Body Number, Platelet Capacity to Accumulate 14C-5-HT and Platelet Density in the Bernard-Soulier and Hermansky-Pudlak Syndromes (1979) (45)
Fibrinogen binding and ADP-induced aggregation in platelets from diabetic subjects. (1981) (44)
Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study. (1989) (44)
Human Platelet Activation In The Absence Of Aggregation: A Calcium-Dependent Phenomenon Independent Of Thromboxane Formation (1982) (43)
Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity. (1989) (42)
Plasminogen Paris I: congenital abnormal plasminogen and its incidence in thrombosis. (1983) (41)
Studies on the mode of reaction of the first component of complement with platelets: interaction between the collagen-like portion of C1q and platelets. (1977) (40)
Detection of heterozygotes in both parents of homozygous patients with Von Willebrand's disease. (1975) (40)
Anticoagulant activities of a pentosane polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin. (1980) (40)
Fraxiparin, a low‐molecular‐weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in mice (1994) (39)
Release of Elastolytic Activity from Blood Platelets (1970) (39)
Effect of kappa-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig. (1996) (39)
Modulation of endothelial cells growth induced by heparin. (1986) (39)
Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells. (1993) (38)
Clinical manifestations and erythrocyte adhesion to endothelium in sickle cell syndrome (1985) (38)
Adsorption of factor VIII antigen-activity complex by collagen. (1978) (37)
Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology (1985) (36)
The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome". (1996) (35)
New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides. (1998) (35)
Platelet-collagen interactions. (1977) (34)
A Leu7Pro mutation in the signal peptide of platelet glycoprotein (GP)IX in a case of Bernard–Soulier syndrome abolishes surface expression of the GPIb–V–IX complex (2002) (34)
Platelets from "giant platelet syndrome (BSS)" are discocytes and normal sized. (1978) (33)
Megakaryocytopoiesis: characterization and regulation in normal and pathologic states. (1991) (33)
Absence of tubular structures and immunolabeling for von Willebrand factor in the platelet alpha-granules from porcine von Willebrand disease. (1986) (33)
Evidence that a collagen-derived nonapeptide is a specific inhibitor of platelet-collagen interaction. (1980) (33)
Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function. (1978) (33)
Histochemical and ultrastructural characterization of subendothelial glycoprotein microfibrils interacting with platelets. (1982) (32)
Biological findings in Von Willebrand's pedigrees: implications for inheritance (1967) (31)
Platelet interaction with polymerizing fibrin in Glanzmann's thrombasthenia. (1981) (31)
In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5‐fluorouracil (1996) (31)
Studies on a human blood platelet protease with elastolytic activity. (1973) (30)
Reassessment of protein tyrosine phosphorylation in thrombasthenic platelets: evidence that phosphorylation of cortactin and a 64-kD protein is dependent on thrombin activation and integrin alphaIIb beta3. (1997) (30)
Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III). (1990) (30)
Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig. (1996) (30)
Thrombocytopoietic effect of heparin given in chronic immune thrombocytopenic purpura (1995) (29)
Specific and quantitative method for estimation of platelet adhesion to fibrillar collagen. (1979) (28)
Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin. (1997) (28)
Comparative degradation of adenylnucleotides by cultured endothelial cells and fibroblasts. (1978) (28)
Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4. (1992) (27)
Platelet-collagen interaction: adhesion of human blood platelets to purified (CB4) peptide from type III collagen. (1978) (27)
Effect of a collagen derived octapeptide on different steps of the platelet/collagen interaction. (1983) (27)
The In Vitro Effect of Ticlopidine on Fibrinogen and Factor VIII Binding to Human Platelets (1981) (27)
Serum angiotensin-converting enzyme: an endothelial cell marker. Application to thromboembolic pathology. (1988) (27)
Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with Anagrelide (1999) (26)
A large alteration in the human platelet glycoprotein IIIa (integrin beta 3) gene associated with Glanzmann's thrombasthenia. (1993) (26)
Hermansky‐pudlak platelets: Further studies on release reaction and protein phosphorylations (1987) (26)
Prelining of polytetrafluoroethylene grafts with cultured human endothelial cells isolated from varicose veins. (1989) (25)
The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDS. (1990) (25)
The common pathway for alpha‐ and gamma‐thrombin‐induced platelet activation is independent of GPIb: a study of Bernard‐Soulier platelets (1990) (25)
Platelet adhesion to type I collagen and alpha 1 (I)3 trimers: involvement of the C-terminal alpha 1 (I) CB6A peptide. (1978) (25)
Freeze-fracture studies on the plasma membranes of normal human, thrombasthenic, and Bernard-Soulier platelets. (1979) (24)
Erythropoietin and granulocyte colony-stimulating factor increase plasminogen activator inhibitor-1 release in HUVEC culture. (2002) (24)
Indapamide Inhibits Human Platelet Aggregation in vitro: Comparison with Hydrochlorothiazide (1993) (24)
PML/RARα fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association (2010) (24)
Reversible translocation of glycoprotein Ib in plasmin‐treated platelets: consequences for platelet function (1993) (24)
A role for glycoprotein IIb‐IIIa complex in the binding of IgE to human platelets and platelet IgE‐dependent cytotoxic functions (1986) (23)
Dynamic coronary fibrinolysis evaluation in patients with myocardial infarction and unstable angina by specific plasma fibrin degradation product determination. (1987) (23)
Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate. (1983) (23)
Platelet fibrinogen (1965) (23)
Adenovirus-mediated gene therapy with an antiangiogenic fragment of thrombospondin-1 inhibits human leukemia xenograft growth in nude mice. (2003) (23)
Abnormal phospholipid organization in Bernard-Soulier platelets (1983) (23)
Platelet factor VIII-related antigen: studies in vivo after transfusion in patients with von Willebrand disease. (1978) (23)
Ex vivo expansion of megakaryocytic cells. (2000) (22)
Separation of human blood platelet elastase and proelastase by affinity chromatography. (1975) (22)
Changes in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosis. (1988) (21)
Abnormality of glycoprotein Ib in two cases of "pseudo"-von Willebrand's disease. (1985) (21)
Platelet function, factor VIII, fibrinogen, and fibrinolysis in Nigerians and Europeans in relation to atheroma and thrombosis (1978) (21)
Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities. (1984) (21)
Abnormal platelet function, population, and survival-time in a boy with congenital absent radii and thrombocytopenia. (1972) (21)
Factors involved in cell adhesion to vascular endothelium. (1983) (21)
Identification of an endothelial cell growth-inhibitory activity produced by human monocytes. (1990) (21)
Platelet‐derived growth factor (PDGF) in type 1 diabetes mellitus (1989) (20)
Aggregation of human gel-filtered platelets. Requirement of apyrase and proteins. (1972) (20)
Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4. (2003) (20)
Signal transduction in normal and pathological thrombin-stimulated human platelets. (1987) (20)
ANGIODYSPLASIA IN ACQUIRED VON WILLEBRAND DISEASE (1976) (19)
Microfibrils (MF) Platelet Interaction: Requirement Of Von Willebrand Factor In Platelet Adhesion To A Placenta Microfibrillar Component (PMC) (1981) (19)
Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34+ cord blood cells: comparative studies with transforming growth factor β1 (1996) (19)
Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase. (1984) (19)
KRDS--a tetrapeptide derived from lactotransferrin--inhibits binding of monoclonal antibody against glycoprotein IIb-IIIa on ADP-stimulated platelets and megakaryocytes. (1988) (19)
Platelet aggregation induced by the C‐terminal peptide of thrombospondin‐1 requires the docking protein LAT but is largely independent of αIIb/β3 (2003) (19)
Congenital platelet disorders. (1988) (19)
C1 and human platelets. II. Detection by immunological methods and role. (1976) (18)
Role of Surface Glycoproteins in Human Platelet Function (1976) (18)
Differential effects of recombinant human interleukin‐13 on the in vitro growth of human haemopoietic progenitor cells (1995) (18)
Analysis of von Willebrand factor mRNA from the lung of pigs with severe von Willebrand disease by using a human cDNA probe. (1988) (18)
Interleukin‐3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG‐01 cells (1994) (18)
Binding of 14C-ADP by thrombasthenic platelet membranes. (1976) (18)
Effect of thrombin on maturing human megakaryocytes. (1993) (18)
C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG. (1976) (18)
Platelet adhesion to type III collagen: Involvement of a sequence of nine aminoacids from α1(III)CB4 peptide (1979) (18)
Carboxy‐terminal peptides (C1–24 and C13–24 but not C1–13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin (1996) (18)
Parallels between milk clotting and blood clotting: opportunities for milk-derived products (1991) (17)
Inherited platelet disorders. (1983) (17)
VON WILLEBRAND DISEASE AS AN ENDOTHELIAL-CELL ABNORMALITY (1975) (17)
Complete profiling of some eicosanoids using glass capillary gas chromatography with flame ionization detection: application to biological samples. (1980) (17)
[Elastinolytic activity associated with blood platelets]. (1969) (17)
Platelet aggregation in washed suspensions. (2009) (17)
Constitutive and selective expression of basic fibroblast growth factor in human leukaemia cell lines (1995) (16)
Identification of a normal human bone marrow cell population co‐exmessin‐g megakaryocytic and erythroid markers in culture (1992) (16)
Relative involvement of GPIb/IX-vWF axis and GPIIb/IIIa in thrombus growth at high shear rates in the guinea pig. (1997) (16)
[Platelets and aging]. (1992) (16)
Effect of periwinkle alkaloids in idiopathic thrombocytopenic purpura. (1971) (16)
Thrombospondin, a negative modulator of megakaryocytopoiesis. (1997) (16)
Effect of Glucosamine on Platelet-Collagen Reaction (1968) (15)
Region of the Clq molecule involved in the interaction between platelets and subcomponent Clq of the first component of complement. (1980) (15)
Glanzmann's thrombasthenia. (1989) (15)
Are megakaryocytes and endothelial cells sisters? (1993) (15)
Platelets : physiology and pathology (1977) (15)
Further Studies on a Specific Platelet Antibody Found in Bernard‐Soulier Syndrome and its Effects on Normal Platelet Function (1979) (15)
Influence of lithium on aggregation, release-reaction and function of human platelets. (1972) (14)
Interactions of platelets with standard heparin and low molecular weight fractions (1986) (14)
Platelet glycoproteins. (1984) (14)
Studies of in vitro megakaryocytopoiesis in adult immune thrombocytopenic purpura (ITP) (1991) (14)
Abnormal phosphoinositide metabolism and protein phosphorylation in platelets from a patient with the grey platelet syndrome (1987) (14)
Release reaction in washed platelet suspensions induced by kaolin and other particles. (2009) (14)
Dissociation between fibrinogen and fibrin interaction with platelets in patients with different subtypes of Glanzmann's thrombasthenia: studies in an ex vivo perfusion chamber model (2002) (14)
Platelet acquired defect in PDGF and β thromboglobulin content in hairy cell leukaemia: improvement after interferon therapy (1987) (14)
Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism. (1988) (13)
ABNORMAL CALCIUM TRANSPORT INTO MICROSOMES OF GRAY PLATELET SYNDROME (1987) (13)
The polymerization of fibrinogen Dusart (Aα 554 Arg→Cys) after removal of carboxy terminal regions of the Aα-chains (1993) (13)
The defective prothrombin consumption in Bernard-Soulier syndrome. Hypotheses from 1948 to 1982. (1983) (13)
Is Fibrinogen the Plasma Co-factor in ADP-induced Human Platelet Aggregation? (1965) (13)
Interaction of platelets with endothelial cells: activation of a novel neutral protease. (1989) (13)
Probing Conformational Changes in the I-like Domain and the Cysteine-rich Repeat of Human β3 Integrins following Disulfide Bond Disruption by Cysteine Mutations (2001) (13)
A Randomized Double-Blind Study Between a Low Molecular Weight Heparin Kabi 2165 and Standard Heparin in the Prevention of Deep Vein Thrombosis in General Surgery: A French Multicenter Trial (1989) (13)
Inhibition effects of KRDS, a peptide derived from lactotransferrin, on platelet function and arterial thrombus formation in dogs. (1992) (12)
Defective thrombolysis due to collagen incorporation in fibrin clots. (1988) (12)
Discrimination between Activity of (α2–3)‐Sialyltransferase and (α2–6)‐ Sialyltransferase in Human Platelets Using p‐Nitrophenyl‐β‐D‐galactoside as Acceptor (1982) (12)
Further investigations on Bernard-Soulier platelet abnormalities. (1981) (12)
Erythrocyte adhesion to cultured endothelium and glycaemic control in Type I (insulin-dependent) diabetic patients (1986) (12)
Factor VIII related antigen in platelets of patients with Von Willebrand's disease. (1977) (12)
Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease. (1976) (12)
Platelet surface glycoprotein changes in patients with cerebral ischemia. (1991) (12)
In vivo inhibition of megakaryocyte and platelet production by platelet factor 4 in mice. (1991) (12)
Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activator. (1984) (12)
Ratio Adenosine Triphosphate/Adenosine Diphosphate in Platelet-rich Plasma in Hæmorrhagic Disorders (Von Willebrand and Glanzmann Disease) (1963) (11)
Vasculogenesis from embryonic bodies of murine embryonic stem cells transfected by Tgf-beta1 gene. (1998) (11)
Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood. (2000) (11)
Ionophore A 23187 and thrombasthenic platelets : a model for dissociating serotonin release and thromboxane formation from true aggregation. (1979) (11)
Evidence that a collagen derived octapeptide inhibits fibrinogen binding to platelets stimulated by collagen and not by ADP. (1985) (11)
Mg++ - and Ca++-Induced Platelet Aggregation and ADP (1970) (11)
Negative regulation of mitogen-activated protein kinase activation by integrin alphaIIbbeta3 in platelets. (1997) (11)
Molecular membrane organization in normal and pathological platelets: changes in inositide metabolism and membrane fluidity. (1985) (11)
Diffuse Severe Digestive Angiodysplasia in Bernard-Soulier Syndrome (1995) (11)
In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets. (1984) (11)
The Elastase-Like Enzyme of Platelets (1979) (11)
A Glanzmann thrombasthenia family associated with a TUBB1‐related macrothrombocytopenia (2019) (11)
The phosphoprotein that regulates platelet Ca2+ transport is located on the plasma membrane, controls membrane-associated Ca2(+)-ATPase and is not glycoprotein Ib beta-subunit. (1991) (10)
Regulation of Megakaryocytopoiesis (1999) (10)
Elastolytic protease in blood platelets. (1971) (10)
Binding of heparin to human microvascular endothelial cells and the effect on proliferation. (1988) (10)
BIOCHEMISTRY AND IMMUNOLOGY OF PLATELET MEMBRANES WITH REFERENCE TO GLYCOPROTEM COMPOSITION * (1981) (10)
[Expression of cyclin B in megakaryocytes and cells of other hematopoietic lines]. (1993) (10)
Platelet shape change: induction by trypsin and release of an acidic macroglycopeptide from washed human platelets and from those of three cases of Glanzmann's thrombasthenia. (1974) (10)
First Component of Complement and Thrombosis (1981) (10)
4 Cytokines acting on committed haematopoietic progenitors (1994) (10)
Prolonged remission in Raynaud's phenomenon after prostacyclin infusion. (1986) (10)
A Ser752→Pro substitution in the cytoplasmic domain of β3 in a Glanzmann thrombasthenia variant fails to prevent interactions between the αIIbβ3 integrin and the platelet granule pool of fibrinogen (2002) (10)
Selective stimulation of human platelet lipoxygenase product 12-hydroxy-5,8,10,14-eicosatetraenoic acid by chlorpromazine and 8-(n,n-diethylamino)-octyl-3,4,5-trimethoxybenzoate. (1982) (10)
PDGF modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets. (1986) (10)
A monoclonal antibody directed against an epitope in the NH2-terminal region of native human plasminogen induces a modification of its functional properties (1997) (9)
[Fibrinogen, a vascular risk factor]. (1993) (9)
Defective adhesion of blood platelets to vascular microfibrils in the Bernard-Soulier syndrome. (1993) (9)
Further characterization of human platelet ADP binding sites using 5' AMP. Demonstration of a highly reactive population of sites. (1980) (9)
Pharmacological approaches of fibrin gel architecture modulation and thrombus degradation: its implication in atherogenesis and thromboembolism disease. (1994) (9)
[EXTRA-ARTICULAR LESIONS OF PSEUDOTUMORAL TYPE IN HEMOPHILIACS]. (1965) (8)
Granulocytic sarcoma of the small intestine: a case report. (1988) (8)
Pharmacology of platelet-suppressive agents. (1979) (8)
The calcium inhibitor SR33805 reduces intimal formation following injury of the porcine carotid artery. (2001) (8)
[Hemostasis and cancer]. (1974) (8)
A platelet defect in a patient with eosinophilic leukaemia: absent ristocetin-induced platelet aggregation associated with a reduced platelet sialic acid content. (2009) (8)
Functional Antithrombin‐III Variant (41 Pro→Leu) Identified by Liquid Secondary Ion Mass Spectrometry (1991) (8)
Effect of Reserpine on 14C-Serotonin Uptake by Human Platelet Populations (1972) (8)
1α, 25 — Dihydroxyvitamin D3 modulates the growth of 3T3 cells and human skin fibroblasts stimulated by platelet-derived growth factor (1986) (8)
Impaired Prothrombin Consumption in Bernard-Soulier Syndrome Is Corrected In Vitro by Human Factor VIII (1997) (8)
Enhanced expression of urokinase activity on U 937 cell line by 1,25-dihydroxyvitamin D3 induction. (1988) (8)
Thrombin-Induced Platelet Factor Va Formation in Patients with a Gray Platelet Syndrome (1987) (8)
New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1. (1992) (7)
Current perspectives in the treatment of thrombotic disorders. (1989) (7)
Guinea pig blood: a model for the pharmacologic modulation of the GPIb/IX-vWF axis. (1996) (7)
Dissociation between human platelet agglomerating activity and factor VIII procoagulant activity of bovine plasma preparations by chemical treatment. I. Effect of neuraminidase. (1973) (7)
Antithrombin Activity of Normal and Pathological Cerebrospinal Fluid (1961) (7)
Cytokines acting on committed haematopoietic progenitors. (1994) (7)
[Treatment of hemophilia B with a plasma fraction rich in antihemophilic B factor (P.P.B.)]. (1959) (7)
Evidence for C1 on human platelets. (1973) (7)
1-Deamino (8-D-arginine) vasopressin infusion partially corrects platelet deposition on subendothelium in Bernard-Soulier syndrome: the role of factor VIII. (1999) (7)
Hemostasis disorders in diabetes mellitus. (1985) (7)
Interaction of adenosine and adenylnucleotides with the human platelet membrane. Further characterization of the ADP binding sites. (1980) (7)
Adenosine diphosphate metabolism by cultured human umbilical endothelial cells (1979) (7)
Further Studies on the Glycoprotein Composition of Normal Human, Bernard-Soulier and Thrombasthenic Platelets (1977) (7)
Platelet membrane glycoproteins and platelet functions during storage in the presence of a proteinase inhibitor. (1991) (7)
Specific determination and identification of cross-linked fibrin degradation products in patients under thrombolytic therapy for myocardial infarction. (1987) (7)
Platelet adhesion to type III collagen : involvement of a sequence of nine aminoacids from alpha 1 (III) CB peptide. (1979) (6)
Dysfibrinogenemia and thrombosis. (1991) (6)
Platelet Elastase and Leukocyte Elastase are two Different Entities (1977) (6)
A comparison of the inhibitory effects of prostacyclin and carbacyclin on platelet adhesion to collagen. (1982) (6)
Dominant inherited familial factor VIII deficiency (Von Willebrand disease) associated with thrombocytopathic thrombocytopaenia. (Biologic and genetic implications). (1974) (6)
Deficit en facteur Hageman. (1958) (6)
Binding of 14C-ADP to normal human and thrombasthenic platelet membranes. Study of the dissociation of the nucleotide from its receptors. (1978) (6)
Complement (C6) and platelet activation by thrombin in humans. (1979) (6)
A Ser752-->Pro substitution in the cytoplasmic domain of beta3 in a Glanzmann thrombasthenia variant fails to prevent interactions between the alphaIIbbeta3 integrin and the platelet granule pool of fibrinogen. (2002) (6)
Abnormal cAMP‐induced phosphorylation of rap 1, protein in grey platelet syndrome platelets (1994) (6)
Study of 10 cases of congenital dysfibrinogenemia: clinical and molecular biological aspects (1985) (5)
Inhibition of platelet collagen interactions by the C1s subcomponent of the first component of complement (1981) (5)
Dual structural requirements for multilineage hematopoietic-suppressive activity of chemokine-derived peptides. (2000) (5)
Vincristine-induced thrombocytosis in the rat. Thrombopoiesis and platelet populations. (1973) (5)
Increased interaction of vascular endothelium and leucocytes after administration of antiplatelet serum: role in the developing vascular defect. (1979) (5)
[Willebrand's disease. Clinical, genetic and biological study (apropos of 22 cases)]. (1961) (5)
The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo. (1998) (5)
Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin. (1989) (5)
[Importance of the structure of the clot in thrombolysis]. (1987) (5)
Purification of platelet proteases: Activation of proelastase by a trypsin‐like enzyme (1977) (5)
Regulation of human megakaryocytopoiesis. (1990) (5)
[Endothelial cells and adhesion of red cells in diabetes and sickle cell anemia. Quantitative and qualitative aspects]. (1984) (5)
[Norgestrienone, a possible therapeutic agent in hereditary angioneurotic edema]. (1986) (5)
Absence of side effects of hydroxyethylstarch 200 in a porcine model of experimental arterial thrombosis. (1991) (5)
Hypercalcemia in chronic myelogenous leukemia: evidence for excessive parathyroid hormone secretion. (1985) (4)
Degradation of fibrinogen by tissue plasminogen activator. Consequences for fibrin polymerization. (1990) (4)
Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia. (1989) (4)
Effect of somatostatin on platelet aggregation and plasma factor VIII level in normal man. (1977) (4)
Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines. (1996) (4)
[Evolutive study of the ultrastructure of megakaryocytes in a case of idiopathic thrombopenic purpura before, 12 days, and 5 months after splenectomy]. (1969) (4)
Interaction of platelets with purified macromolecules of the arterial wall. (1975) (4)
Substrate Specificity of Leukocyte and Platelet Elastases (1978) (4)
Association of autoimmune thrombocytopenic purpura (AITP), Graves' disease and ovarian carcinoma. (1991) (4)
[Circulating lupus-type anticoagulant, a risk factor for thrombosis by inhibition of protein C activation]. (1986) (4)
Effect of Pentoxifylline on Monocyte Adhesion to Endothelial Cells in Diabetic Patients (1990) (4)
Freeze-fracture cytochemistry of wheat germ agglutinin and concanavalin A receptors on the plasma membrane of normal, Bernard-Soulier, and thrombasthenic platelets. (1986) (4)
[Hemorrhagic thrombocytic dystrophy (interaction of platelets and the Willebrand factor)]. (1973) (4)
Comparison of von Willebrand Disease and Bernard-Soulier Syndrome (1977) (3)
Control of megakaryocyte development: from basic data to clinical results. (1993) (3)
[Effects of heparin on megakaryocytopoiesis. From fundamental data to clinical applications]. (1997) (3)
[Platelet factor 4 acts as both inhibitor and protector of hematopoietic precursor cells: possible mechanism of action]. (1995) (3)
The Anti-aggregating Peptide KRDS Impairs a-granule Release, Whereas RGDS Does Not. (1995) (3)
Weibel-Palade bodies in pig megakaryocytes. (1988) (3)
["In vivo" disorder of platelet adhesiveness in Willebrand's disease and Glanzmann's thrombasthenias. Trial interpretation]. (1962) (3)
[The role of thrombosis in renal allograft rejection (author's transl)]. (1976) (3)
Inherited abnormalities of platelet glycoproteins. (1983) (3)
[Posttransfusion purpura: identification of a new platelet antigen Leka. A case]. (1984) (3)
[Chronic thrombopenic purpura. Hyperthyroidism, pretibial myxedema and L.A.T.S]. (1970) (3)
[The behavior of the blood platelets in hemorrhagic diseases]. (1967) (3)
Diffusion et validation des tests génétiques en France (2009) (3)
[Micromethod of collagen extraction from human skin biopsy (application to the study of bleeding diseases)]. (1969) (3)
Thrombopathie et thrombasthénie. (1968) (3)
Discrimination between activity of (alpha 2-3)-sialyltransferase and (alpha 2-6)-sialyltransferase in human platelets using p-nitrophenyl-beta-D-galactoside as acceptor. (1982) (3)
Thrombocytopenias and thrombocytopathies. (1994) (3)
ABNORMAL MEGAKARYOCYTE RELEASE AND MYELOFIBROSIS (1984) (3)
Introduction to the Vth Congress of the International Society on Thrombosis and Haemostasis, held in Paris, July, 1975 (1976) (3)
[Acquired Von Willebrand disease with chronic lymphocytic leukaemia and angiodysplasia (author's transl)]. (1977) (3)
Treatment of antithrombin III deficiency with danazol. (1984) (3)
Effect of Adrenaline on Thrombosthenin (1971) (3)
Modification of membrane properties of erythrocytes by PGI2. (1989) (3)
A1205 TitleMECHANISMS OF BLEEDING REDUCTION INDUCED BY APROTININ DURING CARDIOPULMONARY BYPASS (1990) (3)
Platelet Antibodies and Circulating Immune Complexes in Thrombocytopenic Purpura (1979) (2)
[Inhibition of fibrinogen conversion during myeloma]. (1958) (2)
[Binding of factor VIII/Willebrand to Bernard-Soulier and thrombasthenic platelets (author's transl)]. (1981) (2)
Biochemical messengers of platelet activation. (1985) (2)
[Thrombopathy and thrombasthenia]. (1968) (2)
[Guy-Crescent Fagon (1638-1718), physician to the Sun King]. (1996) (2)
Quantitation of megakaryocytopoiesis by computerized automatic in culture image analysis. (1998) (2)
[Glanzmann's disease. Clinical, biological and pathogenic study apropos of 5 cases]. (1961) (2)
[Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy]. (1995) (2)
Contribution of heparin endothelial cell binding to its inactivation (1986) (2)
Evidence that the Monoclonal Antibody an 51 is Directed Against Platelet Membrane Glycoprotein IB (1983) (2)
Recent data on thrombasthenia. (2009) (2)
[CORRELATIONS BETWEEN BLEEDING TIME AND PLATELET ADHESIVENESS "IN VIVO" DURING VARIOUS HEMORRHAGIC STATES]. (1964) (2)
Defective vWF-Fibrin-GPIb interaction causes impaired prothrombin consumption in Bernard-Soulier Syndrome (2003) (2)
Two simple methods for the quantitative evaluation of platelet adhesion to collagen. (1976) (2)
[Monthly cyclic thrombopenic purpura and megakaryocytopenia]. (1962) (2)
Isolation of Dense Bodies from Human Blood Platelets Using Discontinuous Metrizamide Gradients (1979) (2)
Effect of reserpine on 14C serotonin uptake by thrombasthenic platelets. (1974) (2)
[Epsilon aminocaproic acid and hematurias in hemophiliacs. 3 cases of transient unilateral renal obstruction]. (1966) (2)
[Platelet membrane glycoprotein defect, molecular basis for the abnormal adhesion of platelets to the subendothelium in thrombocytic hemorrhagic dystrophy]. (1975) (2)
[Physiology of hemostasis. 3. Primary hemostasis]. (1970) (2)
[BILATERAL ISCHEMIC NECROSIS IN A CASE OF SEVERE CONGENITAL HYPOFIBRINOGENEMIA]. (1964) (2)
[Prolongation of bleeding time and collagen anomalies]. (1970) (2)
Mg plus plus- and Ca plus plus-induced platelet aggregation and ADP. (1970) (2)
Role of fibrin polymerization in fibrinolysis: Comparison between polymerisable and unpolymerisable fibrins in the potentiating effect of plasminogen activation by tissue-type plasminogen activator (tpA) (1986) (2)
[Effects of acetylsalicylic acid in hemorrhagic diseases]. (1956) (2)
Visualisation of lectin binding sites on the surface of human platelets using lectins adsorbed to gold granules (1980) (2)
Giant (Bernard-Soulier) Platelets are Normal Sized in Circulation (1977) (2)
[Role of C1 subcomponents in platelet aggregation induced by aggregated IgG]. (1977) (2)
Platelet-associated fibrinogen: Conformational change of fibrinogen induced by its adsorption to platelet-surface (1986) (2)
Study of the interaction between plasminogen and fibrinogen degradation products using immunoenzymological assay (1985) (2)
COMPARISON BETWEEN THE POTENTIATING EFFECT INDUCED BY FIBRIN(OGEN) DERIVATIVES ON PLASMINOGEN ACTIVATION INDUCED BY EITHER STREPTOKINASE OR TISSUE PLASMINOGEN-ACTIVATOR (1984) (2)
[Molecular abnormalities in recurrent thromboembolic disease]. (1983) (2)
Rapid evolution in the immunochemical findings of a gamma heavy chain disease. (1988) (2)
[Course of the manifestations associated with the antiprothrombinase circulating anticoagulant]. (1986) (2)
[Congenital blood accelerin deficiency; Owren's parahemophilia]. (1956) (2)
Heparin cofactor II in adult glomerulopathy and nephrotic syndrome. (1991) (2)
Platelet Aggregation by Thimerosal (1976) (2)
Human Platelet Isolation from Whole Blood on Metrizamide Gradients (1979) (2)
[Blood platelets and fibrinolysis]. (1961) (2)
[Transfusion of platelets loaded with periwinkle alkaloids as a treatment for chronic idiopathic thrombocytopenic purpura (author's transl)]. (1979) (2)
Adhesion and aggregation of human platelets to rabbit subendothelium. A new approach for investigation: Specific antibodies (1977) (1)
A 13-24 C-terminal peptide related to PF4 accelerates hematopoietic recovery of progenitor cells in vivo in mice treated with 5-fluorouracil. (1997) (1)
[Erythroplastin: coagulant factor of the erythrocytes. Relation to proaccelerin, proconvertin and the Stuart factor]. (1961) (1)
The polymerization of fibrinogen Dusart (A alpha 554 Arg-->Cys) after removal of carboxy terminal regions of the A alpha-chains. (1993) (1)
Defective Ristocetin Aggregation Not Attributable to a Von Willebrand or Bernard-Soulier Type Defect (1977) (1)
A new and simple method of quantifying the bleeding time. (1975) (1)
Acquired haemorrhagic diathesis in sideroblastic anemia (megakaryocytopathy and thrombocytopathy). (2009) (1)
[Vascular subendothehlium: structure and functions (author's transl)]. (1976) (1)
[Treatment of Raynaud's syndrome with ketanserin. Clinical, biological and hemodynamic aspects]. (1987) (1)
γ M Globulin and Thrombasthenie Platelets (1970) (1)
On peut rester géiphage à Paris (1975) (1)
[Variant of Paris-I Lariboisière thrombasthenia, a molecular anomaly of the IIb-IIIa platelet glycoprotein complex]. (1983) (1)
[Synovial inflammation and coagulation factors. II. Biological study of synovial fluid in serogically positive rheumatoid arthritis]. (1972) (1)
L'anticoagulant circulant de type lupus, facteur de risque thrombotique par inhibition de l'activation de la protéine (1986) (1)
[Diagnosis and treatment of Willebrand's disease]. (1969) (1)
Megakaryocytes and Platelet Disorders (1997) (1)
Immunocytochemical study of a Ca(2+)-ATPase enzyme in the human megakaryocytic lineage. (1991) (1)
Identification of the platelet alloantigen (PlA1) in circulating immune complexes of normal human sera (2004) (1)
[Physiology of hemostasis. I. Megakaryocytes and platelets]. (1968) (1)
Gastrointestinal angiodysplasia in constitutional thrombocytopathies. (1997) (1)
Inhibition of platelet aggregation by cationic protein from polymorphonuclear leukocytes. (1976) (1)
Inherited abnormalities of platelet glycoproteins (1981) (1)
[Constitutional thrombopathies: from the clinical description of rare diseases (Glanzmann thrombasthenia and Bernard-Soulier syndrome) to the development of new antithrombotic agents]. (1998) (1)
Platelet-Collagen Interaction : Adhesion to Alpha 1 (I) CB6 and Alpha 1 (III) CB4 Peptides from Calf-Skin Collagen (1977) (1)
[A specific marker of thrombolysis: DDE complex]. (1987) (1)
[Gray platelet syndrome, an example of myelofibrosis of megakaryocytic origin]. (1991) (1)
[TREATMENT OF IDIOPATHIC THROMBOPENIC PURPURA]. (1964) (1)
[Letter: One can remain a geophagist in Paris]. (1975) (1)
[Idiopathic thrombopenic purpuras. Clinical and etiological considerations on 341 personal cases]. (1970) (1)
[Hemophilia in triplets]. (1977) (1)
Platelet Coagulant Activities in Metrizamide Gradient Platelets : Application to Bernard-Soulier and Thrombotic Disorders (1977) (1)
5-HT uptake in platelet populations. (1976) (1)
Some Considerations about the Purification and Standardization of Collagen from Patients with Prolonged Bleeding Time (1975) (1)
[Defect of activation of the fibrinolytic system after local anoxia in 3 cases of thromboembolic disease]. (1971) (1)
[Study of platelet aggregation during diabetic retinopathy. Influence of hypophysectomy]. (1974) (1)
352 I-25 OH vitamin D3 enhances plasmin generation on monoblastic cell line (1988) (1)
1 alpha, 25-dihydroxyvitamin D3 modulates the growth of 3T3 cells and human skin fibroblasts stimulated by platelet-derived growth factor. (1986) (1)
[Quantitative study of bleeding time and platelet function during thrombopenic purpura]. (1974) (1)
[FUNCTIONAL RELATION BETWEEN ERYTHROPLASTIN (ERYTHROCYTE COAGULANT FACTOR) AND PLASMA FACTORS: PROACCELERIN (V), PROCONVERTIN (VII) AND STUART FACTOR(X)]. (1964) (1)
THROMBOEMBOLIC DISEASE ASSOCIATED WITH DEFECTIVE LYS‐PLASMINOGEN BINDING RELATED TO AN ABNORMAL FIBRIN (1983) (1)
[Familial hemorrhagic diseases associating a prolonged bleeding time with a plasma prothromboplastin factor deficiency]. (1957) (1)
[Platelet anomaly in an eosinophilic myelophroliferative syndrome]. (1976) (1)
[Immunochemical study of protein anomalies in platelets of patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome]. (1979) (1)
Relationship Between Platelet Density and Number of Dense Bodies (1977) (1)
Human blood platelet elastase and proelastase. Activation of proelastase and release of elastase after ahesion of platelets to collagen. (1977) (1)
[Chemokines and the regulation of hematopoiesis]. (1998) (1)
[Surgical treatment of thrombopenic purpura and thrombocytopenia]. (1962) (1)
[Anti-thrombotic effect of lacto-transferrin peptides]. (1990) (1)
[The receptor of adenosine-dephosphate on the human platelet membrane (author's translation)]. (1976) (1)
PHARMACOLOGICAL STUDIES OF PLATELET ANTIAGGREGANTS USING AN IN VITRO MODEL OF PRIMARY HEMOSTASIS. (1987) (1)
Modulation of Endothelial Cell Proliferation by Monocyte-Derived Cytokines (1992) (1)
[Utilization of P.P.B. in congenital deficiencies of a factor of the prothrombin complex (Stuart factor deficiency, true hypoconvertinemia)]. (1959) (1)
[The stypven time]. (1961) (0)
L'effect anti-thrombotique des peptides de la lactotransferrine (1990) (0)
New peptides, therapeutic use and pharmaceutical compositions containing them (1999) (0)
[Platelet adhesiveness to glass in Willebrand's disease: application to genetic study]. (1968) (0)
[Future anticoagulants appear less dangerous]. (2003) (0)
[Thrombotic thrombocytopenic purpura or Moschcowitz syndrome]. (1982) (0)
Blood Platelets (1914) (0)
[Structural anomaly of the fibrin clot with reduction of lys-plasminogen binding, as a cause of familial thrombosis]. (1982) (0)
[Prostaglandins, thromboxanes and leukotrienes. Their role in cardiovascular diseases, allergic reactions and inflammation]. (1984) (0)
[Congenital anomalies of the human blood platelet, models for understanding mechanisms of platelet secretion: gray platelet disease]. (1981) (0)
[Paris-I-Lariboisière variant thrombasthenia. Functional disorder of human platelet aggregation, glycoprotein-independent]. (1985) (0)
STUDY OF PRIMARY HEMOSTASIS IN THE RAT AFTER WHOLE-BODY IRRADIATION. (1965) (0)
[New views on hemostasis]. (1976) (0)
[THE BIOLOGICAL SYNDROME OF CONGENITAL AFIBRINEMIA]. (1965) (0)
Arachidonic Acid-Induced Platelet Aggregation Independent Of Cyclooxygenase And Lipoxygenase (1981) (0)
[Purified collagens and blood platelets. (Effect of certain "osides" on platelet adhesion and aggregation)]. (1967) (0)
The elastase-like enzyme of platelets. (1980) (0)
Proteases in Blood Platelets: Collagen Induced Activation of Proelastase by a Trypsin-Like Enzymes (1977) (0)
[Psychological problems of leukemia]. (1962) (0)
[Dissociated congenital hypoplastic cytopenias: congenital thrombocytopenic purpura with congenital megacaryocytopenia and neutropenia]. (1956) (0)
[Plasma surface tension and coagulation disorders]. (1965) (0)
Amino acid Sequence of a Peptide from Type III Collagen Involved in Platelet Adhesion (1979) (0)
Immunologie Studies in von Willebrand’s Disease (1976) (0)
RapidEvolution inthe Immunochemical Findings of a GammaHeavyChainDisease (1988) (0)
[Hageman factor deficiency]. (1958) (0)
[Disorders of hemostasis in malignant hemopathies]. (1968) (0)
[Cerebro-meningeal hemorrhage of a newborn revealing a congenital factor 13 deficiency (fibrin stabilizing factor. FSF)]. (1969) (0)
A technic for the separation of rat platelet populations on a discontinuous sucrose gradient (application for platelet preservation). (1972) (0)
DISSOCIATION BETWEEN DDE LEVEL AND RECANALIZATION IN PATIENTS UNDERGOING THROMBOLYTIC THERAPY FOR MYOCARDIAL INFARCTION. A POSSIBLE EXPLANATION (1987) (0)
[Criteria and limitations of the diagnosis of Willebrand's disease]. (1967) (0)
French-Chinese meeting on “Genomics 2000: Science and Mankind” organized by the Académie des Sciences de l’Institut de France and the Chinese Academy of Sciences, held in Les Pensières-Annecy (France) on May 3–6, 2000 (2001) (0)
Megacaryocytoasthenia and megacaryocytopathy, new names, old diseases. (1972) (0)
Red wine derived compounds and their antiatherogenic properties : preliminary results of the programme Wine and Health (1997) (0)
[From logical discovery to therapy (author's transl)]. (1981) (0)
[Correction by hypophysectomy of platelet hyperaggregation observed during diabetic retinopathy]. (1973) (0)
Thrombocytopenia with thrombocytopathy possibly related to abnormalities of intracellular Ca++ fluxes and followed by the development of leukaemia. (2009) (0)
[Elastinolytic protease in human blood platelets]. (1970) (0)
[Positive and negative regulation of megakaryocytopoiesis]. (1996) (0)
Lipids and ristocetin-induced platelet aggregation (1974) (0)
[Variations of platelet sialic acid in constitutional and acquired thrombopathies]. (1971) (0)
Haemophilia in a Female (1971) (0)
EFFECT OF RADIATION ON PLATELETS IN VITRO (1964) (0)
[Physiology of hemostasis. II. Fibrinolysis]. (1969) (0)
[Interreaction of platelets and plasma in the initial phase of coagulation. Technic of study in the normal subject of the role of the platelets. Effect of contact]. (1960) (0)
Congenital thrombocytic dystrophy (1957) (0)
[Current treatment of idiopathic thrombopenia]. (1971) (0)
[USE OF THE P.P.B. PREPARATION IN THE TREATMENT OF HEMORRHAGIC DIATHESIS WITH CONGENITAL DEFICIENCY OF COAGULATION FACTORS]. (1963) (0)
Monoclonal Antibodies and Platelet Functions (1983) (0)
87. Ex vivo fibrin architecture modulation: a new way of venous thrombosis prophylaxis for patients with high risk (1998) (0)
Contents, Vol. 15, 1985 (1985) (0)
C1 and human platelets. Decrease in chronic lymphocyte leukemia. Effect of lymphocytes. (1975) (0)
[DETERMINATION OF MAGNESIUM AND CALCIUM IN HUMAN BLOOD PLATELETS]. (1964) (0)
[Thrombopenic purpura with cyclic megakaryocytopenia]. (1973) (0)
[Platelets and inflammation. 2. In vitro action of carrageenan on human and rat blood platelets. Comparison with prostaglandin E2 action]. (1973) (0)
[Limitations of the diagnosis of the hemophilia A carrier]. (1966) (0)
[Cellular and metabolic pharmacology: an aspect of vascular research]. (1987) (0)
[The discovery of blood platelets]. (1999) (0)
[THE ROLE OF FIBRINOGEN IN PRIMARY HEMOSTASIS]. (1965) (0)
patients with the gray platelet syndrome Specific protein and glycoprotein deficiencies in platelets isolated from two (2011) (0)
French Society of Hematology. 16th meeting of the Study Group on Hemostasis and Thrombosis. Lyon, France. March 30-31, 1979. Abstracts of papers presented. (1979) (0)
[DEVELOPMENTAL DATA ON THE RADIOLOGICAL OSTEOARTICULAR LESIONS OF HEMOPHILIA]. (1963) (0)
Interaction of the First Component of Complement in Platelet Adhesion and Aggregation Induced by Collagen and Aggregated IgG (1978) (0)
SERIC ANGIOTENSIN CONVERTING ENZYME : AN ENDOTHELIAL CELL MARKER (application to thrombo-embolic pathology) (1987) (0)
Composition glycosaminoglycan / megakaryocytic growth factor therapeutic use (1994) (0)
DDE COMPLEX DETERMINATION AS A SPECIFIC MARKER FOR FIBRINOLYSIS (1987) (0)
[FATAL IDIOPATHIC THROMBOPENIC PURPURAS]. (1964) (0)
platelets and megakaryocytes monoclonal antibody against glycoprotein IIb-IIIa on ADP-stimulated KRDS--a tetrapeptide derived from lactotransferrin--inhibits binding of (2013) (0)
[The influence of psychological factors on the scholastic achievements of the hemophiliac]. (1966) (0)
[Present indications for hormone therapy and splenectomy in the treatment of idiopathic thrombopenic purpura]. (1956) (0)
[Interaction between the platelets and the vessel wall. Part 3: Investigation]. (1980) (0)
[New treatments for Raynaud's syndrome]. (1988) (0)
Allain defended (1993) (0)
Monocyte inhibitory activity for endothelial cell proliferation is decreased in type 1 insulin dependent diabetes mellitus (1988) (0)
[Attempted induction of an experimental thrombosis in rabbits by means of purified collagen]. (1969) (0)
INCREASED SPONTANEOUS NUMBER OF MEGAKARYOCYTE COLONIES IN ESSENTIAL THROMBOCYTHEMIA (ET) (1987) (0)
[Cellular aspects of thrombosis in the diabetic]. (1982) (0)
[Analysis of the platelet functions. Adhesion and aggregation of platelets with purified collagen]. (1968) (0)
[Study of urinary and blood amino acids during different blood diseases]. (1959) (0)
Studies on the Organisation of Glycoproteins and Proteins in Human Platelet Membranes (1979) (0)
The modulatory effect of phenolic extracts on smooth muscle cell activity (1998) (0)
[HEMOPHILIC PSEUDOTUMORS (APROPOS OF 3 CASES)]. (1964) (0)
Fragments de pf4 modifies et compositions pharmaceutiques les renfermant (1999) (0)
Glanzmann's thrombasthenia: a defect of the gene coding for platelet glycoprotein IIB? (1987) (0)
Gamma M globulin and thrombasthenic platelets. (1970) (0)
193 Determination of specific plasma fibrin degradation products in patients with pulmonary embolism associated with deep-vein thrombosis treated by fibrinolytic agents (1988) (0)
[Problems due to disorders of hemostasis in patients with platelet anomalies]. (1968) (0)
Interaction of blood platelets with ; adult bovine aorta: Requirement fo: (platelet aggregation/vessel wall/glycoprotein/plasma factor) (2016) (0)
[Current report on using immunosuppressive agents in the treatment of chronic idiopathic thrombopenic purpura]. (1970) (0)
[Effect of ADP and thrombin on normal platelet proteins]. (1967) (0)
[Platelets and inflammation. I. Study in rats of quantitative and qualitative change in rat platelets during an acute inflammatory reaction (carrageenan pleurisy)]. (1973) (0)
[Study of the effect of ADP and thrombin on fibrinogen, the stabilising factor of fibrin and thrombosthenine in human blood platelets]. (1967) (0)
Therapy of chronic autoimmune purpura (ITP) (1997) (0)
Subject Index Vol. 2, 1973/74 (1973) (0)
Subject Index, Vol. 7, 1978 (1978) (0)
[Further data on the dissociation of the superprecipitation and ATPase activity of thrombosthenin prepared from frozen and lyophilized human platelets]. (1966) (0)
Tension superficielle plasmatique et maladies de la coagulation. (1965) (0)
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Inhibition of In Vitro Angiogenesis by Platelet Factor-4-Derived Peptides and Mechanism of Action (2016) (0)
Contents, Vol. 2, 1973-74 (2004) (0)
[Recent data on thrombasthenia and the Bernard-Soulier syndrome]. (1978) (0)
[Evaluation of hemostasis in thrombotic pathology? A critical study apropos of 200 records]. (1983) (0)
[VISCOUS METAMORPHOSIS OF THE PLATELETS IN GLANZMANN-NAEGELI THROMBOASTHENIA. (APROPOS OF 9 CASES)]. (1964) (0)
Les thrombopathies constitutionnelles (1984) (0)
1338 – ABNORMAL PLATELET FOR UNDERSTANDING PLATELET PHARMACOLOGY (1978) (0)
Modulation of erythrocyte-endothelium interactions by fibrinogen fibronectin and antibodies (1982) (0)
Plasma Fibrin Degradation Products Evolution in Patients with Deep‐Vein Thrombosis Treated with a Low Molecular Weight Heparin Fraction (CY222) and Standard Heparin (1989) (0)
[Of chance and necessity: the discovery of the Fletcher factor (prekallikrein)]. (1981) (0)
Immunological study of platelet glycoproteins and alloantigens in families of patients with Glanzmann's thrombasthenia. (1992) (0)
[Inhibition of coagulation due to the blood platelets; in vivo and in vitro study]. (1955) (0)
[Deficit of Stuart factor; biological study]. (1958) (0)
[Synovial inflammation and coagulation factors. I. General study]. (1972) (0)
[Initial phase of blood coagulation]. (1953) (0)
["VISCOUS METAMORPHOSIS" OF PLATELETS IN GLANZMANN'S THROMBASTHENIA (APROPOS OF 8 CASES)]. (1963) (0)
[Elastinolytic activity associated with blood platelets]. (1969) (0)
[Quantification of platelet associated IgG in thrombocytopenic purpura (authors transl)]. (1979) (0)
Inhibition of platelet collagen interactions by the C1s subcomponent of the first component of the first component of complement. (1981) (0)
Bone marrow transplantation between normal and von Willebrand pigs: An interesting model when studying the roles of the von Willebrand factor (1992) (0)
Internal Ca2+ Interfering Drugs Alter Arachidonic Acid Metabolism And Inhibit In Vitro Platelet Functions (1981) (0)
[Afibrin acquired]. (1959) (0)
[Bernard-Soulier syndrome from the clinical description (1948) to the molecular era (1977) (author's transl)]. (1977) (0)
Traitement intensif du myélome multiple. Discussion (2003) (0)
In Vitro and in Vivo Antithrombotic Effect of a Collagen-Derived Octapeptide (1987) (0)
[Aggregation effectors and platelet populations]. (1972) (0)
[Effect of radiations in vitro on human and rat blood platelets]. (1965) (0)
[BLEEDING TIME]. (1964) (0)
Inhibition Of Platelet Adhesion To Collagen By Prostaglandins (PGI2 PGE1, PGD2) Its Possible Correlation With Camp/ Adenylate Cyclase System (1981) (0)
Altitude Influence on the Rare Occurence of Thrombosis on the Andes Plateaus (1975) (0)
with Von Willebrand ' s disease . parents of homozygous patients Detection of heterozygotes in both (0)
Blood Platelet Membranes Symposium (1977) (0)
PLATELET DERIVED GROWTH FACTOR (PDGF) BINDS TO HUMAN PLATELETS AND MODULATES PLATELET ACTIVATION (1987) (0)
Thrombasthenia: A Model for Studying Platelet Activation in the Absence of Aggregation (1979) (0)
[Interactions between the platelets and the vessel wall. Part 1: Physiology (author's transl)]. (1980) (0)
EFFECT OF RADIATIONS IN VITRO ON BLOOD PLATELETS OF MAN AND THE RAT. (1965) (0)
[Analysis of platelet functions: measurement of the coagulating activity of the so-called platelet factor 3]. (1967) (0)
Effects Of A Monoclonal Antibody To Human Platelet Glycoprotein I On Platelet - Von Willebrand Factor Subendothelium Interactions (1981) (0)
[Hemostasis disorders in the alcoholic]. (1976) (0)
[CONSIDERATIONS ON PROLONGATION OF BLEEDING TIME IN CONGENITAL AFIBRINOGENEMIA]. (1963) (0)
Epidemiology of Thrombosis in Nigerians. Study of Platelet and Fibrinolytic Parameters (1975) (0)
Isolation and Properties of Elastase-Like Enzymes from Human Platelets and Pig Aorta (1975) (0)
[Hemophilia: new data, study of 35 cases]. (1955) (0)
[Case of gasoline poisoning]. (1951) (0)
Genetic abnormalities in platelet function. (1978) (0)
[In vitro bleeding time]. (1987) (0)
MONITORING OF DEEP VEIN THROMBOSIS BY D DIMER DETERMINATION. INFLUENCE OF HEPARIN REGIMEN (1987) (0)
Platelet-collagen reaction and bleeding syndrome. (1970) (0)
73. Platelet interaction with fibrin depends upon fibrin physical properties. Consequences on fibrin rigidity (1998) (0)
[Treatment of Willebrand's disease]. (1964) (0)
[Corticotherapy in prolonged bleeding time]. (1963) (0)
[Effect of retinal vein thrombosis and coagulation factors in young adults (author's transl)]. (1982) (0)
[Studies of hemophilia; clinical and biological study of 35 cases (groups A, b and A')]. (1954) (0)
Interaction between coagulation factors VII and X and lipoproteins (1992) (0)
Blood Constituents and the Vessel Wall (1993) (0)
Triglyceride metabolism and hyperactivity of coagulation factor VII (1992) (0)
[INDICATIONS FOR FRESH BLOOD TRANSFUSIONS IN BLOOD PLATELET DISORDERS]. (1964) (0)
CULTURED HUMAN MICROVASCULAR ENDOTHELIAL CELLS SYNTHESIZE CYCLOOXYGENASE METABOLITES FROM ARACHIDONIC ACID IN RESPONSE TO LEUKOTRIENES C4 AND D4 (1987) (0)
Subject Index, Vol. 15, 1985 (1985) (0)
Identification of the Platelet Alloantigen ( PI A 1 ) in Circulating Immune Complexes of Normal Human (0)
Heparin‐like substances: acidic mucopolysaccharides from sea cucumbers and their biological effects (1986) (0)
Proceedings of the IVS workshop held in Paris 17 December 1993 on “Fibrinogen, a vascular risk factor” (1994) (0)
[Study of the proteases of human blood platelets: purification of an elastase]. (1972) (0)
Lupus anticoagulant enhances endotoxin or TNF induced monocyte procoagulant activity (1992) (0)
[Letter: platelet aggregation and assay of Willebrand factor during diabetes mellitus]. (1975) (0)
[An association of penicillin and vitamin B12 in retarded growth]. (1955) (0)
Characterization of the Binding of Adenosine Diphosphate to Human Platelet Membranes (1977) (0)
[Microscopic study of the normal and pathological blood clot (constitutional and experimental thrombasthenia). Effect of magnesium and ATP]. (1963) (0)
[Platelet functions in diabetes with angiopathy (author's transl)]. (1979) (0)
[Letter: Platelet C1 in lymphoid syndromes]. (1976) (0)
Is there a dichotomy between the clinician and the pathologist in hematology? (1987) (0)
[INTERMITTENT IDIOPATHIC THROMBOPENIC PURPURAS]. (1964) (0)
[Bleeding time]. (1972) (0)
[Study of hemophilia A carriers]. (1966) (0)
Variation of the Proelastase/Elastase Ratio in Human Blood Platelet Populations (1972) (0)
[ETIOLOGY, CLINICAL SIGNS AND DEVELOPMENT OF IDIOPATHIC THROMBOPENIC PURPURAS]. (1964) (0)
[Constitutional thrombopathies]. (1984) (0)
[PLATELET AGGREGATION AND ADHESION TO CONNECTIVE TISSUE OF RAT MESENTERY (IN CONSTITUTIONAL HEMORRHAGIC DISEASES)]. (1965) (0)
[Hemorrhagic syndrome due to deficiency of Rosenthal's prothromboplastic factor (P.T.A.)]. (1956) (0)
[Study of a case of true congenital hypoproconvertinemia]. (1959) (0)
Monomeric and dimeric peptides, their use for protecting cells and their methods of preparation (1993) (0)
individual immunoprecipitates in crossed-immunoelectrophoresis Characterization of human platelet glycoprotein antigens giving rise to (2011) (0)
NEW CONCEPT OF DECREASED THROMBOLYSIS RELATED TO AN ABNORMAL CLOT STRUCTURE (1984) (0)
Studies of the Interaction of Platelets with Highly Purified Macromolecules of the Arterial Wall (1975) (0)
[Platelet function (aggregability, adhesivity) in atherosclerotic hyperlipidemic subjects]. (1969) (0)
IMPORTANCE OF CONFORMATIONAL CHANGE OF FIBRINOGEN INDUCED BY SURFACE ADSORPTION (1987) (0)
[Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta]. (1983) (0)
Heparin: a 70 year history from 1914 to 1984. (1984) (0)
[The treatment of idiopathic thrombopenic purpura in children]. (1963) (0)
[Ocular hemorrhages and capillary fragility]. (1967) (0)
[Enzymatic activity of blood platelets. Determination of glutamic oxalic acetic transaminase]. (1960) (0)
[Not Available]. (1957) (0)
[Aggregation effectors and human platelet populations]. (1972) (0)
[Sporadic hemophilia A with transitory refractory state]. (1960) (0)
[Demonstration of recessive transmission in Willebrands diseases. Detection of heterozygotes]. (1974) (0)
[New data concerning Willebrand's disease (angiohemophilia)]. (1960) (0)
[Action of adrenaline on platelet thrombosthenin]. (1969) (0)
Antibodies as a Cause for Platelet Functional Defects (1977) (0)
[Physiology of hemostasis]. (1970) (0)
[Two cases of attenuated hemophilia (hemophilia A'); injurious effects of estrogen therapy in one case]. (1955) (0)
[Studies on functional synergy between erythroplastin (a coagulation factor of the erythrocytes) and coagulating snake venoms]. (1962) (0)
Interaction of the First Component of Complement (CI) in Platelet Adhesion and Aggregation Induced by Collagen (1977) (0)
Localization of Factor VIII Antigen in Platelets and Megakaryocytes of Normal and Von Willebrand Patients.(Electron Microscopy Studies with Peroxidase Labelled Antibodies) (1977) (0)
Contents, Vol. 7, 1978 (1978) (0)
[Study of primary hemostasis in rats after total irradiation]. (1965) (0)
[Surgery in von Willebrand's disease. (A propos of 3 personal studies)]. (1969) (0)
[Interactions between the platelets and the vessel wall. Part 2: physiopathology (author's transl)]. (1980) (0)
Abnormal Platelets as Models for Understanding the Mechanisms of Platelet Function (1979) (0)
Serotonin Release from Filtered and Unfiltered Human Platelets Induced by Antigen/Antibody Complexes of Different Valencies (1977) (0)
2/2 mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response (2001) (0)
[Blood serotonin & hemorrhagic diseases]. (1958) (0)
General and Local Factors in Arterial Thrombosis: Platelets, Prostaglandins and Postulates (1984) (0)
Inhibition by Peptidic Fragments of Clq of Platelet - Collagen Interactions (1979) (0)
[Reduction of Willebrand activity in patients with chronic kidney failure]. (1976) (0)
[Parameters of hemostasis in Behçet's disease]. (1983) (0)
[Comparative study of the effects of various drugs (curariform, ATPase inhibitors, antiserotonin) on muscle contraction and clot retraction]. (1965) (0)
Growth and differentiation factors in megakaryocytopoiesis. (1991) (0)
Rapid binding of ADP to a small population of platelet receptor sites (1979) (0)
[Fibrinopenia in the course of promyelocytic leukemias. Treatment with heparin]. (1968) (0)
Early biochemical events in thrombin-induced activation of normal and pathological platelets (1986) (0)
Spontaneous aggregation of platelets. (1972) (0)
[Platelet thromboplastic factors]. (1957) (0)
Is it a Dichotomy between the Clinician and the Pathologist in Hematology (1988) (0)
[Constitutional and acquired thrombopathies]. (1981) (0)
[Autoimmune thrombocytopenic purpura. Clinical and therapeutic retrospective study of 544 cases (author's transl)]. (1981) (0)
[Current therapy of idiopathic thrombopenic purpuras]. (1974) (0)
[Atherosclerosis, degenerative disease? Inflammatory disease? Cancerous disease?]. (1991) (0)
[Hemorrhagic action of acetylsalicylic acid during blood diseases]. (1955) (0)
6. Risk factors of arterial thrombosis. Fibrinogen Dusart (1996) (0)
[Apropos of the surgical treatment of thrombopenic purpura]. (1962) (0)
MEMBRANE SIGNAL TRANSDUCTION IN PLATELETS WITH ALTERED RELEASE REACTION (1987) (0)
[EFFECT OF RADIATIONS IN VITRO ON THE BLOOD PLATELETS]. (1964) (0)
[The endothelium: protective barrier or irritating thorn]. (1982) (0)
[STUDY OF HEMOSTASIS IN 14 CASES OF EPULIS]. (1964) (0)
[Vitamin B12; nutrition factor]. (1954) (0)

This paper list is powered by the following services:

Jacques Philippe Caen's Academic­Influence.com Rankings

Jacques Philippe Caen's Degrees

Why Is Jacques Philippe Caen Influential?

Jacques Philippe Caen's Published Works

Published Works

Jacques Philippe Caen's AcademicInfluence.com Rankings